Wednesday, March 18, 2026

🌿🛡️ Exploring Natural Antioxidants for Cardiac Protection ️

Presenter: Pranjal P Gujarathi

Presentation Type: Oral Presentation 🎤

Title: Cardioprotective Potential of Machilus macrantha Against Adriamycin-Induced Cardiotoxicity: An In Vivo Study🌿

Revolutionizing

This research explores the cardioprotective effects of the medicinal plant Machilus macrantha, demonstrating its antioxidant potential in protecting the heart from chemotherapy-induced damage.

Key Findings & Scientific Insights

🔬 Strong antioxidant activity confirmed through DPPH radical scavenging assay.
🧪Protection against Doxorubicin-induced cardiotoxicity in experimental models.
🥚 Improvement in ECG abnormalities and cardiac function parameters.
📊 Significant reduction in cardiac injury markers including CK-MB and LDH.
🛡️ Restoration of endogenous antioxidants CAT, SOD, and GSH.

Why This Study Matters

🌿 Highlights the potential of plant-based cardioprotective therapies.
🫀 May help reduce cardiac side effects associated with chemotherapy drugs.
🔬 Supports the development of novel complementary therapeutic approaches in cardiovascular medicine.

👩‍🔬 About Speaker

Pranjal P Gujarathi is an Assistant Professor of Pharmacology at SVKM NMIMS Global University and a PhD scholar at Bhagwan Mahavir University.

She previously served as a Senior Research Fellow at Bhabha Atomic Research Centre, working on toxicity studies of radiopharmaceuticals. Her research focuses on cardioprotection, neuroprotection, dermatology, and alternative medicine systems.

Dr. Gujarathi has authored five books, multiple book chapters, and numerous research publications, and frequently contributes as a reviewer and editor for scientific journals. She has also received several national and international awards, including the Best Woman Researcher Award.

📅 Conference Event Details

Conference: International Conference on Cardiology and Cardiovascular Science (CVS 2026)
Dates: March 26–28, 2026
Format: Virtual Conference
📧 cardiology@mathewsconference.com
📞 +1 (312) 462-4448

🌐 Website: https://cardiology.miconferences.com
🎟 Registration: https://cardiology.miconferences.com/register
🔗 Abstract Submission: https://cardiology.miconferences.com/abstract-submission

Join global experts to explore innovations in cardiovascular prevention, treatment, and integrative healthcare approaches. 🌎🔬

#CVS2026 #Cardiology #CardiovascularScience #HeartHealth #ClinicalCardiology #PreventiveCardiology #MedicalResearch #HealthcareInnovation #GlobalHealth #MedicalConference #VirtualConference #HeartCare #CardioResearch

Tuesday, March 17, 2026

Viral Cardiomyopathy in Young Women: A Rare Case from Papua

Presenter: Evander Banua Rouw

Presentation Type: Oral Presentation 🎤

Title: First case of viral cardiomyopathy in young women in Papua

Revolutionizing

This presentation sheds light on a rare clinical case of viral cardiomyopathy in a young woman from Papua, emphasizing the importance of early diagnosis and guideline-based management in improving patient outcomes.

Key Findings & Scientific Insights

🔬 Identification of viral cardiomyopathy presenting with dyspnea and palpitations in a young adult.
📊 Echocardiography revealed left ventricular dilation with reduced ejection fraction (33%).
💊 Treatment followed standard heart failure guidelines, including diuretics, ARBs, beta-blockers, and supportive therapies.
📈 Follow-up demonstrated significant symptomatic improvement, highlighting the effectiveness of timely medical intervention.
🫀 The case emphasizes the need for increased awareness of cardiomyopathy in young women.

Why This Study Matters

🌍 Heart failure among young adults remains uncommon but clinically significant.
⚕️ Early identification and treatment can greatly improve quality of life and reduce hospitalization risks.
📚 The study contributes to expanding clinical knowledge about cardiomyopathy cases in emerging healthcare regions.

👩🔬 About Speaker

Evander Banua Rouw is a medical doctor practicing at Abepura Regional General Hospital in Papua, Indonesia. A graduate of Christian University of Indonesia, he has developed strong clinical experience in patient care and hospital medicine.

Over the past two years, Dr. Rouw has focused on cardiovascular health, particularly heart failure and cardiomyopathy cases. His clinical work emphasizes early detection, evidence-based treatment, and improving cardiac outcomes for patients in regional healthcare environments.

Through his research presentations and participation in international conferences, Dr. Rouw contributes to global cardiology discussions by sharing unique clinical experiences from Papua, supporting the advancement of cardiovascular knowledge and improved patient care worldwide. 🫀🌍

📅 Conference Event Details

🌐 Website: https://cardiology.miconferences.com
🎟 Registration: https://cardiology.miconferences.com/register
🔗 Abstract Submission: https://cardiology.miconferences.com/abstract-submission

Monday, March 16, 2026

🌿 Ayurveda and Modern Cardiology: A Holistic Approach to Heart Health

Presenter: Prashant Sakharam Bhokardankar
Presentation Type: Oral Presentation
Title: Integrating Ayurveda into Preventive Cardiology and Heart Disease Management

🔍 Revolutionizing Preventive Cardiology

As cardiovascular diseases continue to rise worldwide, healthcare systems are increasingly exploring integrative approaches that combine traditional wisdom with modern medical science. Ayurveda offers a holistic framework that focuses on prevention, lifestyle balance, and natural therapies to promote heart health. 🌿🫀

📊 Key Findings & Scientific Insights

Ayurveda identifies heart disease under the concept of Hridroga, linked to imbalances in the body's doshas.
Emphasis on preventive lifestyle interventions including balanced diet, routine, and stress management. 🧘‍♂️
Herbal medicines and Rasayana therapies may support cardiovascular health and rejuvenation. 🌱
Yoga and meditation play a significant role in improving mental and cardiovascular well-being. 💚
Integrative approaches may help reduce risk factors such as hypertension, obesity, and metabolic disorders.
Combining Ayurvedic knowledge with modern cardiology may improve preventive care and patient-centered treatment strategies. 🔬

🩺 Why This Study Matters

Integrative medicine approaches are gaining attention for their potential to address lifestyle-driven diseases. Ayurveda’s holistic philosophy offers valuable insights into preventive cardiology, focusing on root causes, lifestyle correction, and natural therapies to improve long-term heart health. 🫀🌿

👨‍🔬 About Speaker

Prashant Sakharam Bhokardankar is a Professor and Head of Department at Datta Meghe Ayurvedic Medical College Hospital and Research Centre. He holds a BAMS and MD in Ayurveda (Rasa shastra) from Government Ayurveda College Nanded.

With nearly two decades of experience in Ayurvedic pharmaceutical sciences and research, he has previously worked with renowned organizations such as Dabur and Arya Vaidya Pharmacy.

Dr. Bhokardankar has published numerous research papers and regularly speaks at international conferences, contributing to the integration of Ayurveda and modern healthcare. 🌿📚 🌍

📅 Conference Event Details

Conference: International Conference on Cardiology and Cardiovascular Science (CVS 2026)
Dates: March 26–28, 2026
Format: Virtual Conference
📧 cardiology@mathewsconference.com
📞 +1 (312) 462-4448

🌐 Website: https://cardiology.miconferences.com
🎟 Registration: https://cardiology.miconferences.com/register
🔗 Abstract Submission: https://cardiology.miconferences.com/abstract-submission

Connect with global experts discussing breakthroughs in cardiology, preventive healthcare, and integrative medicine. 🌎🔬

#CVS2026 #Cardiology #CardiovascularScience #HeartHealth #ClinicalCardiology #PreventiveCardiology #MedicalResearch #HealthcareInnovation #GlobalHealth #MedicalConference #VirtualConference #HeartCare #CardioResearch

Saturday, March 14, 2026

⚙️ AngioJet™ Thrombectomy in the Treatment of Visceral Artery Occlusions

Presenter: Bachar Al Haj
Presentation Type: Oral Presentation
Title: The rheolytic thrombectomy AngioJet™ is a safe and technically feasible method for treating acute and sub-acute occluding lesions in the visceral arteries

🔍 Revolutionizing Endovascular Treatment

Visceral artery occlusions affecting renal and mesenteric vessels can lead to serious complications such as organ ischemia and tissue damage. Modern endovascular techniques like rheolytic thrombectomy offer minimally invasive solutions to rapidly restore blood flow. 🫀🩺

📊 Key Findings & Scientific Insights

Retrospective study evaluating 18 patients treated with AngioJet™ thrombectomy. 📊
Focus on acute and sub-acute occlusions in renal and mesenteric arteries.
High technical success rate of nearly 89%, with restored blood flow in most patients. 🫀
Majority of patients were discharged with patent target arteries and clinical improvement.
A few cases required re-intervention, while complications remained minimal.
Results support AngioJet™ as an effective and feasible endovascular therapy. ⚙️

🩺 Why This Study Matters

Endovascular thrombectomy is becoming a key strategy for treating visceral ischemia and complex vascular occlusions. Evidence from this study supports the role of AngioJet™ as a safe and effective tool for restoring arterial circulation and improving patient outcomes. 🔬

👨‍🔬 About Speaker

Bachar Al Haj is a resident doctor at St. Franziskus Hospital and a PhD student at University of Münster.

His research interests include endovascular treatment of visceral ischemia and vascular occlusive diseases, and he has contributed to several scientific publications in this area. 📚

📅 Conference Event Details

🌐 Website: https://cardiology.miconferences.com
🎟 Registration: https://cardiology.miconferences.com/register
🔗 Abstract Submission: https://cardiology.miconferences.com/abstract-submission

Join leading cardiologists and vascular specialists worldwide to explore new advances in cardiovascular medicine. 🌎🔬

#CVS2026 #Cardiology #CardiovascularScience #HeartHealth #ClinicalCardiology #PreventiveCardiology #MedicalResearch #HealthcareInnovation #GlobalHealth #MedicalConference #VirtualConference #HeartCare #CardioResearch

Friday, March 13, 2026

⚙️ Endovascular Thrombectomy for Reno-Visceral Artery Occlusion

Presenter: Bachar Al Haj
Presentation Type: Oral Presentation
Title: Comparison of endovascular aspiration thrombectomy vs. rheolytic thrombectomy for occluded reno-visceral arteries: a single center experience

🔍 Revolutionizing Endovascular Treatment

Visceral ischemia caused by arterial blockage can lead to severe complications affecting organs such as the kidneys and intestines. Modern endovascular thrombectomy techniques offer minimally invasive options to quickly restore blood flow and reduce organ damage. 🫀🩺

📊 Key Findings & Scientific Insights

Analysis of 57 endovascular thrombectomy procedures in patients with mesenteric or renal ischemia. 📊
Comparison between AngioJet™ rheolytic thrombectomy and Penumbra CAT™ aspiration thrombectomy devices. ⚙️
Overall success rate reached nearly 90%, demonstrating the effectiveness of endovascular treatment.
AngioJet™ showed a higher technical success rate and no recurrence in treated cases.
Penumbra™ also demonstrated strong clinical effectiveness with successful vessel recanalization.
Most interventions were performed under general anesthesia with surgical vascular access.
Both approaches were found to be safe and reliable for restoring blood flow in reno-visceral arteries. 🩺

🩺 Why This Study Matters

This research highlights the growing role of advanced endovascular technologies in treating complex vascular conditions. Comparing thrombectomy devices helps clinicians choose the most effective approach for managing renal and mesenteric ischemia, ultimately improving patient outcomes. 🔬🫀

👨‍🔬 About Speaker

Bachar Al Haj is a resident doctor at St. Franziskus Hospital and a PhD student at University of Münster.

His research focuses on endovascular treatments for visceral ischemia and vascular disease, and he has contributed to multiple scientific publications in this field. 📚